Rifkin, R. External Author

Publications

Sort by

Selected publications

  • Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphomaBlood Cancer Journal2014 Academic Article GET IT
    Times cited: 20